Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Nihon KohdenTSE:6849 +0.26%68 Net Margin % is 11.40% as of Mar. 2026, which is 82% above its 10-year median of 6.26. GuruFocus rates TSE:6849 with a GF Score™ of 68/100 and a GF Value™ of 円2,162.06 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 817 Medical Devices & Instruments companies, Nihon Kohden ranks better than 62.18% on this metric.
Net margin is calculated as Net Income divided by its Revenue. Nihon Kohden's Net Income for the
three
months ended in Mar. 2026 was 円8,105 Mil. Nihon Kohden's Revenue for the
three
months ended in Mar. 2026 was 円71,086 Mil. Therefore, Nihon Kohden's net margin for the quarter that ended in Mar. 2026 was 11.40%.
The historical rank and industry rank for Nihon Kohden's Net Margin % or its related term are showing as below:
TSE:6849'
s Net Margin % Range Over the Past 10 Years
Min: 5.25 Med: 6.26 Max: 11.42
Current: 6.17
TSE:6849's Net Margin % is ranked better than 62.18% of 817
companies
in the Medical Devices & Instruments industry
Industry Median: 2.05
vs TSE:6849: 6.17
Nihon Kohden (TSE:6849) Net Margin % Explanation
Although Net Income and Earnings-per-Share (EPS) are the most widely used parameter in measuring a company's profitability and valuation, it is the least reliable. The reason is that reported earnings can be manipulated easily by adjusting any numbers such as Depreciation, Depletion and Amotorization and non-recurring items.
But the long term trend of the net margin is a good indicator of the competitiveness and health of the business.
Nihon Kohden Net Margin % Related Terms
Nihon Kohden Net Margin % Historical Data
* Premium members only.
The historical data trend for Nihon Kohden's Net Margin % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
TSE:6849 vs ABT, SYK, MDT: Net Margin % Comparison
For the Medical Devices subindustry, Nihon Kohden's Net Margin %, along with its competitors' market caps and Net Margin % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Nihon Kohden Net Margin % vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Nihon Kohden's Net Margin % distribution charts can be found below:
* The bar in red indicates where Nihon Kohden's Net Margin % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Nihon Kohden (TSE:6849) has a Net Margin % of 11.40% as of Mar. 2026. Net margin is the ratio of total net income to net sales. View historical data on Nihon Kohden and its competitors. This is 82% above median its historical median of 6.26. Over the past decade, Nihon Kohden's Net Margin % has ranged from 5.25 to 11.42. According to the industry distribution chart, Nihon Kohden ranks #309 out of 817 companies in the Medical Devices & Instruments industry, placing it in the top 37.8%.
Is Nihon Kohden's Net Margin % too high?
Nihon Kohden's current Net Margin % of 11.40% is 82% above median its 10-year median of 6.26. Over the past 10 years, this metric has ranged from a low of 5.25 to a high of 11.42. The Medical Devices & Instruments industry median Net Margin % is 2.05. Nihon Kohden's value of 11.40% is 456.1% above this industry median. Based on the distribution chart, Nihon Kohden ranks #309 out of 817 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Nihon Kohden has a GF Score™ of 68/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Nihon Kohden's Net Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Nihon Kohden ranks #309 out of 817 companies for Net Margin %. This puts Nihon Kohden in the upper half of its industry. The industry median Net Margin % is 2.05. Nihon Kohden's value of 11.40% is 456.1% above this benchmark. Historically, Nihon Kohden's own Net Margin % has ranged from 5.25 to 11.42 over the past decade. While the company's 10-year median is 6.26 vs. the industry median of 2.05, Nihon Kohden has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Net Margin % for a Medical Devices & Instruments company?
The median Net Margin % among Medical Devices & Instruments companies is 2.05, based on 817 companies in the industry. Companies in the top quartile (top 25%) have a Net Margin % significantly above this median, while those in the bottom quartile fall well below. However, Net Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Nihon Kohden's current Net Margin % of 11.40% is 456.1% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Net Margin % mean?
A high Net Margin % can signal that a stock is expensive relative to its fundamentals. Net margin is the ratio of total net income to net sales. View historical data on Nihon Kohden and its competitors. For the Medical Devices & Instruments industry, the median Net Margin % is 2.05 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Nihon Kohden's current Net Margin % is 11.40%, which is 82% above median its own 10-year median of 6.26. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Nihon Kohden stock overvalued right now?
Based on GuruFocus' analysis, Nihon Kohden (TSE:6849) is currently considered Modestly Undervalued. The stock's GF Value™ is 円2,162.06, compared to a current price of 円1,542.50 — trading 28.7% below its estimated fair value. The current Net Margin % is 11.40%, which is 82% above median its 10-year median of 6.26 and 456.1% above the Medical Devices & Instruments industry median of 2.05. Nihon Kohden's overall GF Score™ is 68/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Net Margin % calculated?
Net Margin % is calculated from a company's financial statements. For Nihon Kohden (TSE:6849), the current Net Margin % is 11.40% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Nihon Kohden (TSE:6849) Overvalued in 2026?
Based on GuruFocus' analysis, Nihon Kohden stock appears to be undervalued.
The current stock price of 円1,542.50 is trading 28.7% below its estimated GF Value™ of 円2,162.06.
GuruFocus considers Nihon Kohden to be Modestly Undervalued.
Key valuation signals for TSE:6849:
Net Margin %: 11.40% (82% above median its 10-year median of 6.26)
GF Value™: 円2,162.06 vs. price of 円1,542.50 (28.7% below fair value)
Industry Position: 456.1% above the Medical Devices & Instruments median (#309 of 817)
No single metric tells the full story. See the TSE:6849 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Nihon Kohden Corp is a Japan-based company engaged in the development, manufacturing, and sale of medical electronic equipment. It offers monitoring and diagnostic equipment such as electroencephalographs, electrocardiographs, and patient monitors, along with related systems and consumables. The company operates as a single business segment and manages its activities comprehensively across three reportable regions: Japan, North America, and Other Regions.
68GF Score
Get the complete analysis for TSE:6849
Net Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:6849 has been successfully added to your 
